Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2–) breast cancer is the most common breast cancer subtype in Canada, occurring in 59−65% of women included in the Ontario Cancer Registry [4,5]. Here, ERBB2 is linked to breast cancer.